BG64625B1 - Бензотиено[3,2-c]пиридини, като алфа 2 - антагонисти - Google Patents

Бензотиено[3,2-c]пиридини, като алфа 2 - антагонисти Download PDF

Info

Publication number
BG64625B1
BG64625B1 BG105331A BG10533101A BG64625B1 BG 64625 B1 BG64625 B1 BG 64625B1 BG 105331 A BG105331 A BG 105331A BG 10533101 A BG10533101 A BG 10533101A BG 64625 B1 BG64625 B1 BG 64625B1
Authority
BG
Bulgaria
Prior art keywords
formula
alkyl
compound according
aryl
hydrogen
Prior art date
Application number
BG105331A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG105331A (en
Inventor
Ludo Kennis
Serge Pieters
Francois BISCHOFF
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of BG105331A publication Critical patent/BG105331A/xx
Publication of BG64625B1 publication Critical patent/BG64625B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG105331A 1998-10-06 2001-03-12 Бензотиено[3,2-c]пиридини, като алфа 2 - антагонисти BG64625B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203363 1998-10-06

Publications (2)

Publication Number Publication Date
BG105331A BG105331A (en) 2001-11-30
BG64625B1 true BG64625B1 (bg) 2005-09-30

Family

ID=8234188

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105331A BG64625B1 (bg) 1998-10-06 2001-03-12 Бензотиено[3,2-c]пиридини, като алфа 2 - антагонисти

Country Status (28)

Country Link
US (2) US6426350B1 (xx)
EP (1) EP1117667B1 (xx)
JP (1) JP4580555B2 (xx)
KR (1) KR20010071828A (xx)
CN (1) CN1158287C (xx)
AR (1) AR023678A1 (xx)
AT (1) ATE363485T1 (xx)
AU (1) AU760226B2 (xx)
BG (1) BG64625B1 (xx)
BR (1) BR9913110A (xx)
CA (1) CA2346084C (xx)
CZ (1) CZ20011103A3 (xx)
DE (1) DE69936219T2 (xx)
EE (1) EE04835B1 (xx)
ES (1) ES2288025T3 (xx)
HK (1) HK1039113A1 (xx)
HU (1) HUP0103612A3 (xx)
ID (1) ID28280A (xx)
IL (2) IL142442A0 (xx)
NO (1) NO20011309L (xx)
NZ (1) NZ509911A (xx)
PL (1) PL347184A1 (xx)
RU (1) RU2222542C2 (xx)
SK (1) SK4312001A3 (xx)
TR (1) TR200100954T2 (xx)
TW (1) TWI251595B (xx)
UA (1) UA70334C2 (xx)
WO (1) WO2000020422A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE494000T1 (de) * 2002-03-08 2011-01-15 Max Planck Gesellschaft Verwendung von egfr transaktivierungsinhibitoren für menschlichen krebs
WO2003082825A1 (en) * 2002-04-03 2003-10-09 Orion Corporation Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
EP1757605A4 (en) 2004-04-12 2007-12-19 Taisho Pharmaceutical Co Ltd CYCLIC AMINE COMPOUND

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752820A (en) * 1972-03-20 1973-08-14 Colgate Palmolive Co Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives
FR2570701B1 (fr) * 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
JPH0256485A (ja) * 1988-04-27 1990-02-26 Glaxo Group Ltd ラクタム誘導体
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
ATE247114T1 (de) * 1994-09-12 2003-08-15 Lilly Co Eli Serotonergische modulatoren
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
UA52681C2 (uk) 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

Also Published As

Publication number Publication date
JP4580555B2 (ja) 2010-11-17
US6426350B1 (en) 2002-07-30
EP1117667B1 (en) 2007-05-30
DE69936219T2 (de) 2008-02-07
JP2002526546A (ja) 2002-08-20
NZ509911A (en) 2002-09-27
ID28280A (id) 2001-05-10
NO20011309D0 (no) 2001-03-15
NO20011309L (no) 2001-03-15
KR20010071828A (ko) 2001-07-31
BG105331A (en) 2001-11-30
HUP0103612A2 (hu) 2002-01-28
EP1117667A1 (en) 2001-07-25
TWI251595B (en) 2006-03-21
EE04835B1 (et) 2007-06-15
IL142442A0 (en) 2002-03-10
US20020169178A1 (en) 2002-11-14
AR023678A1 (es) 2002-09-04
ATE363485T1 (de) 2007-06-15
CN1321159A (zh) 2001-11-07
TR200100954T2 (tr) 2001-12-21
EE200100206A (et) 2002-06-17
CN1158287C (zh) 2004-07-21
HK1039113A1 (en) 2002-04-12
UA70334C2 (en) 2004-10-15
WO2000020422A1 (en) 2000-04-13
ES2288025T3 (es) 2007-12-16
CZ20011103A3 (cs) 2001-12-12
CA2346084A1 (en) 2000-04-13
HUP0103612A3 (en) 2003-03-28
SK4312001A3 (en) 2001-12-03
US6774129B2 (en) 2004-08-10
CA2346084C (en) 2010-01-26
DE69936219D1 (de) 2007-07-12
RU2222542C2 (ru) 2004-01-27
BR9913110A (pt) 2001-05-08
AU760226B2 (en) 2003-05-08
PL347184A1 (en) 2002-03-25
AU6089999A (en) 2000-04-26
IL142442A (en) 2006-10-05

Similar Documents

Publication Publication Date Title
EP1019408B1 (en) 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES
RU2230744C2 (ru) Трициклические δ3-пиперидины, способы их получения и фармацевтическая композиция на их основе
BG64871B1 (bg) Трициклични делта 3-пиперидини, като лекарства
BG64625B1 (bg) Бензотиено[3,2-c]пиридини, като алфа 2 - антагонисти
EA003606B1 (ru) 1,5-ПЕНТАНДИИЛЗАМЕЩЕННЫЕ 1,2,3,4-ТЕТРАГИДРОБЕНЗО (ФУРО, АЗО И ТИО) [3,2-c] ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ α-АНТАГОНИСТОВ
MXPA01003514A (en) BENZOTHIENO[3,2-c]PYRIDINES AS&agr;2
MXPA01006353A (en) Benzisoxazoles and phenones as alpha 2-antagonists
MXPA01003512A (en) TRICYCLIC&Dgr;3-PIPERIDINES AS PHARMACEUTICALS